The cross-recognition of viral epitopes by CD8+ T cells is related to viral control during HIV-1 infection and is thus vital to develop a vaccine strategy that can elicit cross-reactive T-cell responses to target the conserved regions of the viral antigens, which is an important requirement for an effective vaccine against HIV-1 variants (35, 36). This evidence concerns the gene CD8A and HIV-1 infection.